

Biotechnologies for New Drug Modalities - 15th April
In-Person Seminar Zwingenberg, Germany | 15 April 2026 | Hosted by BRAIN Biotech AG
Recent advances in computational biology are transforming the way drugs are discovered, designed and manufactured. From AI-supported protein modelling to data-driven bioprocess optimisation, new digital tools are reshaping the boundaries of what is possible in modern therapeutics.
This one-day seminar will bring together experts from industry and academia to examine these developments in depth, sharing practical insights into emerging technologies, current limitations, and the trends defining the future of biotechnology for new drug modalities.
This conference will equip attendees with:
Whether you are involved in early discovery, process development, or biomanufacturing strategy, this event will offer technical depth and actionable insights tailored to the challenges of next-generation therapeutic development.
This event is designed for professionals working in:
Attendees will have the opportunity to engage with speakers and peers, exchange practical insights, and deepen their understanding of how enzyme technologies can support emerging therapeutic formats.
Throughout the event, we will cover:
This structured seminar combines expert presentations with interactive discussion, delivering content that is both technically rigorous and directly relevant to your work.
Spaces for this in-person seminar are limited to ensure engagement and meaningful interaction.
Complete your registration to reserve your place and join colleagues in advancing the science of biotechnology for new drug modalities.
